We offer multiple services in our holding structure
As holding, BioNTech SE encompasses several subsidiaries focused on specific aspects of the BioNTech business. These includes our therapeutic development units as well as certain subsidiaries that also provide external service offerings
BioNTech Small Molecules GmbH BioNTech Small Molecules GmbH offers fully-integrated research services, covering all scientific disciplines for small molecule drug discovery: from hit identification via in silico screening through hit-to-lead and lead optimization to preclinical development. For more information, please contact firstname.lastname@example.org.
BioNTech Diagnostics GmbH BioNTech Diagnostics GmbH develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products through selected partners. The first commercial diagnostic was launched in 2015. More information on MammaTyper can be found here.